Posts in category Healthcare


DexCom, Inc. Shares Jumped 30% Following Positive CMS Decision; Oppenheimer Reiterates Outperform

Oppenheimer analyst Steven Lichtman reiterates an Outperform rating on shares of DexCom, Inc.(NASDAQ:DXCM), following the Center for …

Read more

BTIG Analyst Dives In on DexCom, Inc. (DXCM) As It Wins CMS Reimbursement

DexCom, Inc. (NASDAQ:DXCM) shares rose nearly 30% today, after the U.S. Centers for Medicare and Medicaid Services …

Read more

Cantor Bullish on Celgene Corporation (CELG) After Raising Guidance; Sees 36% Upside

Cantor analyst Mara Goldstein came out today with a bullish note on shares of Celgene Corporation …

Read more

Cowen’s Take On ACADIA Pharmaceuticals Inc. (ACAD) Following Presentation At The J.P. Morgan Healthcare Conference

Cowen analyst Ritu Baral weighs in today on ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), after the drug maker provided …

Read more

Synthetic Biologics Inc: FBR Analyst Provides Takeaways From Management Meeting

After holding a meeting with Synthetic Biologics Inc (NYSEMKT:SYN) management, where an update regarding the company’s …

Read more

These Analysts Neutral On Gilead Sciences, Inc. (GILD) Following Sell Side Meeting

Yesterday, Gilead Sciences, Inc. (NASDAQ:GILD) held an analyst event where management hosted a sell-side meeting …

Read more

J.P. Morgan Reiterates Positive Stance on ACADIA Pharmaceuticals Inc. Following Healthcare Conference

J.P. Morgan analyst Cory Kasimov remains confident on ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) after hosting a …

Read more

Canaccord Slices Price Target On Novadaq Technologies Inc. Following Q4:16 Preannouncement Miss

Novadaq Technologies Inc. (NASDAQ:NVDQ) shares are stumbling 14% after the healthcare company preannounced fourth-quarter results …

Read more

J.P. Morgan Provides Takeaways On Juno Therapeutics Inc (JUNO) Following Healthcare Conference

J.P. Morgan analyst Cory Kasimov is out today sharing insights from the sidelines on Juno …

Read more

Valeant Pharmaceuticals Intl Inc Takes First Steps To Address Leverage: Canaccord

Canaccord analyst Neil Maruoka came out today with a few thoughts on Valeant Pharmaceuticals Intl Inc …

Read more